Delivery Order SPE2DB22D3501-SPE2DB24FWV70

Award Date 9/3/24
Potential Completion Date 9/4/24
Potential Value $8.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract valued at $3,885.55 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of 20,000 unit vials of the pharmaceutical product RECOTHROM, with a completion date of May 2, 2024. This contract is not designated as a set-aside. Amerisourcebergen, a major supplier of pharmaceuticals and medical supplies to the federal government, holds a $999,999,999.00 Indefinite...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation. The $2,403.54 firm fixed-price contract is for the delivery of 20,000 unit vials of RECOTHROM, a pharmaceutical product. This award is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 held by Amerisourcebergen with DLA Troop Support Medical, which...
The Defense Logistics Agency (DLA) awarded a $1,335.30 firm-fixed-price delivery order to AmerisourceBergen Drug Corporation's Corporate Office Division for the supply of 20,000 units of the pharmaceutical product RECOTHROM. This delivery order falls under a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 with DLA Troop Support Medical, which provides a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract has...
This is a $7,763.31 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 20,000 unit vials of the drug RECOTHROM, with a period of performance through May 15, 2024. This order is placed under AmerisourceBergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,066.74 firm-fixed-price delivery order is for the supply of 20,000 unit vials of RECOTHROM, a medical product. The contract has an ultimate completion date of June 25, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This is a $6,851.13 firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 20,000 unit vials of the pharmaceutical product RECOTHROM, with a completion date of July 11, 2025. The contract is not set-aside and was awarded on July 10, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office division. The $2,204.01 firm fixed-price delivery order is for the supply of 20,000 units of the RECOTHROM pharmaceutical product. The contract has a performance period through September 16, 2024 and is not designated as a set-aside. Amerisourcebergen, one of the largest pharmaceutical distributors in the United States, has been awarded...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of RECOTHROM 20,000 unit vials. The contract has a firm fixed price of $3,095.50 and a performance period ending on June 6, 2025. The award is not associated with a set-aside program. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of 20,000 units of RECOTHROM, a medical product. The contract is a Delivery Order with a Firm Fixed Price of $3,053.89 and an Ultimate Completion Date of February 10, 2025. The awarding agency is the Defense Logistics Agency (DLA) Troop Support Medical, which is a defense agency. This contract is not associated with a set-aside designation,...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 20,000 unit vials of the drug RECOTHROM, a medical product, with a ceiling value of $15,010.06. The contract is a Firm Fixed Price Delivery Order, with a period of performance through July 10, 2025. This contract award is not set aside and represents open competition. Amerisourcebergen...
  • SPE2DB22D3501
    Indefinite Delivery Contract
  • SPE2DB22D3501-SPE2DB24FWV70
    Delivery Order

The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $8,154.79 firm fixed price delivery order contract to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the supply of 20,000 unit vials of the pharmaceutical product RECOTHROM, with a completion date of September 4, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous Indefinite Delivery Contracts (IDCs) by DLA and other federal agencies, valued up to $999,999,999, to provide a wide range of essential medical commodities, including specialty medications, generic drugs, and medical supplies, to support military treatment programs and other federal healthcare providers nationwide. This contract award does not include a set-aside designation.

Generated 12/3/24, 9:55 AM